Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22 USD | -6.78% | -13.86% | -29.01% |
05-20 | Insmed Lung Infections Treatment Study Shows Improvement | MT |
05-15 | Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.01% | 3.27B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.57% | 22.1B | |
-8.26% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Mizuho Adjusts Price Target on Insmed to $36 From $35, Keeps Buy Rating